Ausgabe 11/2019
Inhalt (16 Artikel)
The prognostic significance of peritumoral tertiary lymphoid structures in breast cancer
Michael Sofopoulos, Sotirios P. Fortis, Christoforos K. Vaxevanis, Nectaria N. Sotiriadou, Niki Arnogiannaki, Alexandros Ardavanis, Dimitrios Vlachodimitropoulos, Sonia A. Perez, Constantin N. Baxevanis
Potential clinical application of tumor-infiltrating lymphocyte therapy for ovarian epithelial cancer prior or post-resistance to chemotherapy
Donastas Sakellariou-Thompson, Marie-Andrée Forget, Emily Hinchcliff, Joseph Celestino, Patrick Hwu, Amir A. Jazaeri, Cara Haymaker, Chantale Bernatchez
Neoadjuvant cisplatin and paclitaxel modulate tumor-infiltrating T cells in patients with cervical cancer
A. Marijne Heeren, Iske F. van Luijk, Joost Lakeman, Noëlle Pocorni, Jeroen Kole, Renée X. de Menezes, Gemma G. Kenter, Tjalling Bosse, Cornelis D. de Kroon, Ekaterina S. Jordanova
Contribution of Fcγ receptor IIB to creating a suppressive tumor microenvironment in a mouse model
Yuki Kasahara, Hidekazu Shirota, Sho Umegaki, Chikashi Ishioka
Clinicopathologic significance of human leukocyte antigen class I expression in patients with stage II and III gastric cancer
Yujun Park, Jiwon Koh, Yoonjin Kwak, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Woo Ho Kim, Hye Seung Lee
Lenalidomide improves the therapeutic effect of an interferon-α-dendritic cell-based lymphoma vaccine
Caterina Lapenta, Simona Donati, Francesca Spadaro, Laura Lattanzi, Francesca Urbani, Iole Macchia, Paola Sestili, Massimo Spada, Maria Christina Cox, Filippo Belardelli, Stefano M. Santini
Antisense targeting of CD47 enhances human cytotoxic T-cell activity and increases survival of mice bearing B16 melanoma when combined with anti-CTLA4 and tumor irradiation
Anthony L. Schwartz, Pulak R. Nath, Michael Allgauer, Elizabeth C. Lessey-Morillon, John M. Sipes, Lisa A. Ridnour, Y. Maurice Morillon II, Zhiya Yu, Nicholas P. Restifo, David D. Roberts
Schwann cells shape the neuro-immune environs and control cancer progression
German V. Martyn, Galina V. Shurin, Anton A. Keskinov, Yuri L. Bunimovich, Michael R. Shurin
The challenges of adoptive cell transfer in the treatment of human renal cell carcinoma
Zuzana Strizova, Jirina Bartunkova, Daniel Smrz
Naturally occurring cancers in pet dogs as pre-clinical models for cancer immunotherapy
Lidia Tarone, Giuseppina Barutello, Selina Iussich, Davide Giacobino, Elena Quaglino, Paolo Buracco, Federica Cavallo, Federica Riccardo
Adhering to adhesion: assessing integrin conformation to monitor T cells
Cécile Gouttefangeas, Juliane Schuhmacher, Stoyan Dimitrov
CD4+ T cells indirectly kill tumor cells via induction of cytotoxic macrophages in mouse models
Bjarne Bogen, Marte Fauskanger, Ole Audun Haabeth, Anders Tveita
Activation of dendritic cells by targeted DNA: a potential addition to the armamentarium for anti-cancer immunotherapy
Marlene Fyrstenberg Laursen, Emil Kofod-Olsen, Ralf Agger
Understanding TCR affinity, antigen specificity, and cross-reactivity to improve TCR gene-modified T cells for cancer immunotherapy
Timothy T. Spear, Brian D. Evavold, Brian M. Baker, Michael I. Nishimura
Monocytes reprogrammed with lentiviral vectors co-expressing GM-CSF, IFN-α2 and antigens for personalized immune therapy of acute leukemia pre- or post-stem cell transplantation
Julia K. Bialek-Waldmann, Michael Heuser, Arnold Ganser, Renata Stripecke
Arginase-1-based vaccination against the tumor microenvironment: the identification of an optimal T-cell epitope
Evelina Martinenaite, Shamaila Munir Ahmad, Simone Kloch Bendtsen, Mia Aaboe Jørgensen, Stine Emilie Weis-Banke, Inge Marie Svane, Mads Hald Andersen